Lee Golden

Lee Golden

Chief Tech/Sci/R&D Officer at PTC THERAPEUTICS, INC.

Net worth: 2 M $ as of 2024-02-28

56 year
Health Technology
Consumer Services
Health Services

Profile

Currently, Lee Scott Golden occupies the position of Chairman at Coagulation Sciences LLC and Chief Medical Officer at PTC Therapeutics, Inc. In his past career he was Medical Director for Pfizer Inc., Head-Pulmonary at Mesoblast Ltd., Chief Medical Officer for Gemphire Therapeutics, Inc., Head-Cardiovascular & Blood Disorders at Eisai, Inc. and Senior Director-US Medical at Actelion Pharmaceuticals US, Inc. Lee Scott Golden received a doctorate from New York University School of Medicine and an undergraduate degree from the University of Michigan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-14 60,514 ( 0.08% ) 2 M $ 2024-02-28

Lee Golden active positions

CompaniesPositionStart
PTC THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2021-12-31
Chairman -
All active positions of Lee Golden

Former positions of Lee Golden

CompaniesPositionEnd
NEUROBO PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2018-09-17
MESOBLAST LIMITED Corporate Officer/Principal 2016-09-30
Corporate Officer/Principal 2011-06-30
Corporate Officer/Principal 2008-02-29
PFIZER, INC. Chief Tech/Sci/R&D Officer 2004-12-31
See the detail of Lee Golden's experience

Training of Lee Golden

University of Michigan Undergraduate Degree
New York University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lee Golden's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
PFIZER, INC.

Health Technology

PTC THERAPEUTICS, INC.

Health Technology

MESOBLAST LIMITED

Health Technology

Private companies4

Health Technology

Health Technology

Health Services

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Lee Golden